Kuzuya Kazuo | 防衛医科大学校 産婦人科学
スポンサーリンク
概要
関連著者
-
Kudoh K
Department Of Obstetrics And Gynecology National Hospital Organization Nishi Saitama Chuo Hospital
-
Kuzuya Kazuo
防衛医科大学校 産婦人科学
-
Kikuchi Yoshihiro
Ohki Memorial Kikuchi Cancer Clinic for Women
-
Kikuchi Yoshihiro
Department Of Gynecology Ohki Memorial Kikuchi Cancer Clinic For Women
-
Kuzuya Kazuo
Department Of Gynecology Kuzuya Clinic
-
KIKUCHI Yoshihiro
Department of Cardiovascular and Respiratory Medicine, Tohoku University School of Medicine
-
Kikuchi Yoshihiro
Department Of Obstetrics And Gynecology National Defense Medical College Saitama
-
Kudoh Kazuya
Department Of Obstetrics And Gynecology National Hospital Organization Nishi Saitama Chuo Hospital
-
Kita Tsunekazu
Department Of Obstetrics And Gynecology Teikyo University School Of Medicine
-
KITA Tsunekazu
Obstetrics and Gynecology National Defense Medical College
著作論文
- IS-36 Two cases of complete remission of metastatic and relapsed uterine cervical carcinoma using weekly administration of bevacizumab and paclitaxel/carboplatin(Group4 Oncology2,International Session)
- IS-33 Experience of combination therapy with Bevacizumab for recurrent/refractory clear cell carcinoma of the ovary(Group4 Oncology2,International Session)
- K3-IS-2 Discovery of new biomarkers for screening of endometrial cancer of the uterus
- P1-IS-35 Clear cell carcinoma of the ovary : retrospective analysis of Japan Clear Cell Carcinoma Study
- Effect of HER-2/neu overexpression on chemoresistance and prognosis in ovarian carcinoma
- Clinical significance of first-line chemotherapy and complete surgical staging for clear cell adenocarcinoma of the ovary(Oncology 3)
- PDZK1 is a potential target for 1q21-q22 amplification frequently detected in drug resistant ovarian cancer(Oncology 1)
- 4-13.CGH and cDNA micoarray analysis of drug resistance in gynecologic malignancy(Session 6 Oncology 6)
- Inhibitory Effects of Ginsenoside Rh_2 on Tumor Growth in Nude Mice Bearing Human Ovarian Cancer Cells
- Growth-inhibitory Effects of N,N-Diethyl-2-[4-(phenylmethyl)phenoxy]-ethanamine-HC1 Combined with Cisplatin on Human Ovarian Cancer Cells Inoculated into Nude Mice